IN2014DN09097A - - Google Patents

Info

Publication number
IN2014DN09097A
IN2014DN09097A IN9097DEN2014A IN2014DN09097A IN 2014DN09097 A IN2014DN09097 A IN 2014DN09097A IN 9097DEN2014 A IN9097DEN2014 A IN 9097DEN2014A IN 2014DN09097 A IN2014DN09097 A IN 2014DN09097A
Authority
IN
India
Prior art keywords
antibodies
crystallization
methods
disclosure relates
culture supernatant
Prior art date
Application number
Other languages
English (en)
Inventor
Dariusch Hekmat
Bernhard Helk
Henk Konrad Schulz
Benjamin Smejkal
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2014DN09097A publication Critical patent/IN2014DN09097A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
IN9097DEN2014 2012-05-11 2013-05-10 IN2014DN09097A (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261645855P 2012-05-11 2012-05-11
PCT/EP2013/059696 WO2013167720A1 (en) 2012-05-11 2013-05-10 Crystallization methods for purification of monoclonal antibodies

Publications (1)

Publication Number Publication Date
IN2014DN09097A true IN2014DN09097A (el) 2015-05-22

Family

ID=48326319

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9097DEN2014 IN2014DN09097A (el) 2012-05-11 2013-05-10

Country Status (14)

Country Link
US (2) US20150133642A1 (el)
EP (1) EP2846830A1 (el)
JP (1) JP2015517306A (el)
KR (1) KR20150016503A (el)
CN (1) CN104284676B (el)
AU (1) AU2013258006B2 (el)
BR (1) BR112014027994A2 (el)
CA (1) CA2872145A1 (el)
IL (1) IL235483A0 (el)
IN (1) IN2014DN09097A (el)
MX (1) MX2014013754A (el)
RU (1) RU2014150071A (el)
SG (1) SG11201406664SA (el)
WO (1) WO2013167720A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
EA201991293A1 (ru) * 2016-12-23 2020-01-22 Арла Фудс Амба Получение новых препаратов на основе бета-лактоглобулина и связанные с ними способы, варианты применения и продукты питания
WO2018170098A1 (en) * 2017-03-14 2018-09-20 Amgen Inc. Methods directed to crystalline biomolecules
IT202100004496A1 (it) 2021-02-25 2022-08-25 Univ Della Calabria Recupero di farmaci biologici o loro frammenti da soluzioni impure mediante cristallizzazione o precipitazione con membrane
CN116949036B (zh) * 2023-09-11 2023-12-15 成都斯马特科技有限公司 一种快速从腹水中提取核酸的试剂盒及提取方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4731793B2 (ja) * 2000-12-28 2011-07-27 アルセア テクノロジーズ インコーポレイテッド 抗体全体またはそのフラグメントの結晶、ならびにこの結晶を作製および使用するための方法
DK1450847T3 (da) * 2001-11-13 2010-12-13 Genentech Inc Apo2-ligand/TRAIL-formuleringer og anvendelser deraf
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
JP2011507870A (ja) * 2007-12-21 2011-03-10 ジェネンテック， インコーポレイテッド 抗ｃｄ２０抗体の結晶化
CN101320006B (zh) * 2008-07-17 2010-12-01 西北工业大学 蛋白质结晶条件的筛选方法

Also Published As

Publication number Publication date
RU2014150071A (ru) 2016-07-10
US20150133642A1 (en) 2015-05-14
AU2013258006B2 (en) 2016-04-28
MX2014013754A (es) 2015-02-12
CN104284676A (zh) 2015-01-14
KR20150016503A (ko) 2015-02-12
BR112014027994A2 (pt) 2017-06-27
US20170198028A1 (en) 2017-07-13
CA2872145A1 (en) 2013-11-14
IL235483A0 (en) 2014-12-31
AU2013258006A1 (en) 2014-11-06
WO2013167720A1 (en) 2013-11-14
SG11201406664SA (en) 2014-11-27
EP2846830A1 (en) 2015-03-18
JP2015517306A (ja) 2015-06-22
CN104284676B (zh) 2018-11-27

Similar Documents

Publication Publication Date Title
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
IN2014CN03887A (el)
CL2016001190A1 (es) Cultivo de células de mamífero.
HK1199905A1 (en) Culturing of mesenchymal stem cells
SG11201505192RA (en) Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
EP2968549A4 (en) CELL CULTURE METHODS
EP2982742A4 (en) PHOTOBIOREACTOR FOR THE MASS CULTIVATION OF PHOTOSYNTHESEMICROORGANISM
IN2014CN02639A (el)
EP2971014A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
HK1208496A1 (en) Cell culture compositions and methods for polypeptide production
PT2893001T (pt) Método para cultura de células estaminais mesenquimatosas
IN2014DN08481A (el)
GB201103836D0 (en) Conjugation process
NZ703973A (en) Complex chromosome engineering for production of human antibodies in transgenic animals
HK1211977A1 (en) Reactor for bulk production of photosynthetic microorganisms
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MY167584A (en) Method for producing ethanol
IN2014DN09097A (el)
HK1223979A1 (zh) 通過毒胡蘿蔔細胞懸浮培養生產毒胡蘿蔔素
EP2825633A4 (en) PROCESS FOR BREEDING E. COLI CELLS FOR HIGH DENSITY
ZA201504388B (en) Method for culturing pluripotent stem cells
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
SG11201601182QA (en) Method for the clarification of high density crude cell culture harvest
GB201321679D0 (en) Method of culturing vero cells